Management of Essential Hypertension |
Contents
Dedication Preface and Acknowledgments | 1 |
Management of Malignant or Accelerated Hypertension | 12 |
THIAZIDES | 21 |
Copyright | |
50 other sections not shown
Other editions - View all
Common terms and phrases
action acute administration adrenergic adverse reactions aldosterone amiloride angina antihypertensive agent antihypertensive drugs antihypertensive effect associated beta-blocking bethanidine blood pressure body potassium cardiac output catecholamines chapter for complete chlorothiazide chlorthalidone Clin clinical clonidine complete information regarding congestive heart failure contraindicated coronary Curr daily decreased diabetic diarrhea diastolic diazoxide discontinued disease dizziness dosage doses edema Engl essential hypertension excretion furosemide gastrointestinal guanethidine HCTZ headache hepatic hydralazine hydrochlorothiazide hyper hypertensive patients hyperuricemia hypokalemia hypotensive effect increased infarction information regarding sources intravenous JAMA Lancet liver mEq/l metabolism methyldopa mg/day mild minoxidil myocardial nausea nitroprusside occur oral orthostatic hypotension paresthesias pargyline patients receiving peripheral Pharmacol Pharmacological physician plasma potassium supplements potential prazosin pregnancy propranolol rauwolfia reduced reference section renal function renin reported reserpine serum potassium severe hypertension side effects sodium spironolactone studies supine symptoms syndrome TABLE tachycardia Ther therapeutic thiazide diuretic tion toxicity treatment of hypertension triamterene trimethaphan vascular vasodilator